Related Experiment Video

Updated: Jul 29, 2026

Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
09:52

Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii

Published on: July 12, 2013

Proteasome inhibitors block intracellular growth and replication of Toxoplasma gondii

M K Shaw1, C Y He, D S Roos

  • 1Department of Biology, University of Pennsylvania, Philadelphia 19104-6018, USA. mshaw2@sas.upenn.edu

Parasitology
|November 21, 2000
PubMed

Insights

Proteasome inhibitors like lactacystin block Toxoplasma gondii growth and replication by disrupting essential parasite processes. Host cell proteasomes are not required for parasite development, highlighting parasite-specific targets.

Area of Science:

  • Parasitology
  • Cell Biology
  • Molecular Biology

Background:

  • Proteasomes are crucial for protein degradation in eukaryotic cells.
  • Intracellular parasites like Toxoplasma gondii rely on host cell machinery but also possess unique pathways.
  • The role of the parasite's own proteasome in its lifecycle is not fully understood.

Purpose of the Study:

  • To investigate the role of proteasome activity in the intracellular development of Toxoplasma gondii.
  • To determine if proteasome inhibitors affect parasite entry, growth, replication, and morphology.
  • To assess the necessity of host cell proteasome activity for parasite survival.

Main Methods:

  • Treatment of infected host cells with specific proteasome inhibitors (lactacystin, MG-132, proteasome inhibitor 1).
  • Assessment of parasite entry, vacuole establishment, growth, DNA synthesis, and daughter cell budding.
  • Microscopic analysis of parasite morphology, including endoplasmic reticulum (ER)-derived structures.
  • Evaluation of host cell integrity and proteasome activity.

Main Results:

  • Lactacystin inhibited parasite growth, DNA synthesis, and budding but not entry or vacuole formation.
  • Other proteasome inhibitors also blocked parasite growth and intracellular development.
  • Host cell proteasome inhibition did not impede parasite entry or development.
  • Morphological changes, including ER-derived membrane whorls, were observed in lactacystin-treated parasites, suggesting protein degradation defects.

Conclusions:

  • Proteasome activity is essential for Toxoplasma gondii intracellular replication and development.
  • The parasite's proteasome, not the host's, is a critical target for inhibiting parasite growth.
  • Further research is needed to elucidate organelle recycling and the interplay between autophagy and proteasomes in Toxoplasma.

More Related Videos

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay09:49

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

Related Concept Videos

Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...